Literature DB >> 31497424

Esophageal Variceal Band Ligation Interval and Number Required for the Obliteration of Varices: A Multi-center Study from Karachi, Pakistan.

Nazish Butt1, Amanullah Abbasi2, M Ali Khan1, Sehrish Butt3, Syed Masroor Ahmad4.   

Abstract

Introduction Esophageal variceal band ligation (EVBL) is the best form of treatment for variceal bleeding. The frequency of EVBL for the eradication of esophageal varices has no consensus. We evaluated the number and interval of EVBL sessions required for the obliteration of esophageal varices. Methods Esophagogastric varices were treated endoscopically with band ligation on initial presentation and then every after three weeks till the obliteration of the varices. Endoscopic band ligation consists of placing rubber elastic bands on large varices. Frequencies were calculated for qualitative variables and mean ± standard deviations for continuous variables. Results A total of 107 cases with esophagogastric varices were enrolled. Out of them, seven patients with small esophageal varices and large fundal varices were excluded. The remaining 100 with large esophageal varices had EVBL performed. The second session of EVBL was done in 46 patients with large esophageal varices. The third session of EVBL for the obliteration of esophageal varices required in 20 patients with large esophageal varices and the fourth session was required in only two patients. The total sessions required for the complete obliteration for esophageal varices were 2±1. Only one patient developed post-EVBL bleeding one week after band ligation. Conclusion Esophageal variceal ligation was a safe and well-tolerated procedure performed at three-week intervals in patients with large esophageal varices. On average, two to three sessions of EVBL are required for the complete obliteration of esophageal varices.

Entities:  

Keywords:  band ligation; esophageal varices; interval; sessions

Year:  2019        PMID: 31497424      PMCID: PMC6707816          DOI: 10.7759/cureus.4993

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  9 in total

1.  The Baveno VI criteria for predicting esophageal varices: validation in real life practice.

Authors:  Mafalda Sousa; Sónia Fernandes; Luísa Proença; Ana Paula Silva; Sónia Leite; Joana Silva; Ana Ponte; Jaime Rodrigues; João Carlos Silva; João Carvalho
Journal:  Rev Esp Enferm Dig       Date:  2017-10       Impact factor: 2.086

2.  Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension.

Authors:  Roberto de Franchis
Journal:  J Hepatol       Date:  2010-06-27       Impact factor: 25.083

3.  A randomized control trial of bi-monthly versus bi-weekly endoscopic variceal ligation of esophageal varices.

Authors:  Hiroshi Yoshida; Yasuhiro Mamada; Nobuhiko Taniai; Kazuhito Yamamoto; Youichi Kawano; Yoshiaki Mizuguchi; Tetsuya Shimizu; Tsubasa Takahashi; Takashi Tajiri
Journal:  Am J Gastroenterol       Date:  2005-09       Impact factor: 10.864

4.  Endoscopic management of esophageal varices.

Authors:  Joaquin Poza Cordon; Consuelo Froilan Torres; Aurora Burgos García; Francisco Gea Rodriguez; Jose Manuel Suárez de Parga
Journal:  World J Gastrointest Endosc       Date:  2012-07-16

5.  Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study.

Authors: 
Journal:  N Engl J Med       Date:  1988-10-13       Impact factor: 91.245

Review 6.  Current endoscopic therapy of variceal bleeding.

Authors:  Càndid Villanueva; Alan Colomo; Carlos Aracil; Carlos Guarner
Journal:  Best Pract Res Clin Gastroenterol       Date:  2008       Impact factor: 3.043

7.  Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis.

Authors:  Michael Schepke; Gerhard Kleber; Dieter Nürnberg; Jörg Willert; Lydia Koch; Wilfried Veltzke-Schlieker; Claus Hellerbrand; Johannes Kuth; Stefan Schanz; Stefan Kahl; Wolfgang E Fleig; Tilman Sauerbruch
Journal:  Hepatology       Date:  2004-07       Impact factor: 17.425

8.  Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis.

Authors:  Càndid Villanueva; Josep M López-Balaguer; Carles Aracil; Lilian Kolle; Begoña González; Josep Miñana; German Soriano; Carlos Guarner; Joaquim Balanzó
Journal:  J Hepatol       Date:  2004-05       Impact factor: 25.083

9.  Correction of extrahepatic portal vein thrombosis by the mesenteric to left portal vein bypass.

Authors:  Riccardo Superina; Daniel A Bambini; Joan Lokar; Cynthia Rigsby; Peter F Whitington
Journal:  Ann Surg       Date:  2006-04       Impact factor: 12.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.